PathogenDx, Zef Scientific partner to offer microbial testing platform
Category: #health  By Paroma Bhattacharya  Date: 2019-07-04
  • share
  • Twitter
  • Facebook
  • LinkedIn

PathogenDx, Zef Scientific partner to offer microbial testing platform

The propriety technology offered by PathogenDx will set a new standard in Canada for testing bacteria

PathogenDx, Inc., a technology company that provides testing solutions to food, agriculture and botanical testing markets, recently announced it has entered into a strategic partnership with Zef Scientific for sales and distribution of microbial testing in Canada.

Under the agreement, both companies aim to grow their accounts nationally, while the partnership has already wrapped up its first account with a testing lab in Canada.

Reportedly, Zef Scientific works with a number of major equipment manufacturers like Shimadzu and take pride in being able to provide laboratories with multi-vendor solutions. The company’s scope ranges from pharmaceutical laboratories to modern cannabis facilities for testing.

Kevork Kalaydjian, Sales Director at Zef Scientific said that the company’s new partnership with PathogenDx will expand their portfolio to include fungal and bacterial testing through PathogenDx’s offered technology, that is unique and DNA-based.

ZefSci is looking forward to offering new line of instrumentation to the Cannabis market in Canada. The proprietary technology offered by PathogenDx will help set a new standard for testing bacteria in the country, a solution that would make sense, Kalaydjian added.

Milan Patel, Co-Founder and CEO of PathogenDx said in an announcement that the partnership and agreement between PathogenDx and Zef Scientific will offer Canadian Cannabis market new access to ultra-fast microbial testing turnaround times. Owing to major regulatory mandates in order to protect recreational consumer safety and patients, the Canadian market has faced certain supply challenges.

The partnership will offer Canadian retailers, regulators, distributors and growers a chance to shorten approval times and testing with greater precision, while also securing safer and better products to market faster for consumers and patients in Canada, Patel mentioned.

Seemingly, molecular technologies are increasingly being adopted by Cannabis testing labs in order to meet the testing mandates for pathogen and avoid relying on culture based methods. Cannabis was legalized for recreational and medicinal use the previous year.

Source Credit- https://www.biospace.com/article/releases/pathogendx-and-zef-scientific-announce-a-strategic-sales-and-service-distribution-partnership-for-microbial-testing-in-canada/



About Author

Paroma Bhattacharya

Email: [email protected]   

Paroma Bhattacharya

Paroma currently works as a content developer for Algosonline, MSF and a series of alike platforms. Fortified with a post-graduation degree in Journalism and Mass Communication, she delved head long into a writing career, creating resourceful and information enriched ...

Read More

More News By Paroma Bhattacharya

Mirati Therapeutics reveals Phase ½ results of KRAS inhibitor therapy
Mirati Therapeutics reveals Phase ½ results of KRAS inhibitor therapy
By Paroma Bhattacharya

Mirati Therapeutics, an oncology company that engages in the development of targeted therapies, recently released its clinical trial results for MRTX849. Reportedly, MRTX849 is a KRAS G12C inhibitor and the data from P...

Best Buy to offer free next-day delivery feature on various products
Best Buy to offer free next-day delivery feature on various products
By Paroma Bhattacharya

Online retailers are always launching new and attractive deals during the holiday season, as it grosses the highest sale time for the year. Several retailer rollout out attractive offers, such as discounts or complimen...

Nature Tech Corp partners with Aldevron for gene therapy manufacturing
Nature Tech Corp partners with Aldevron for gene therapy manufacturing
By Paroma Bhattacharya

The global cell and gene therapy sector is expected to witness a thriving period of growth over the forthcoming years. In fact, owing to the favorable growth conditions across the industry, numerous biotechnology and p...